Trampas Extracelulares de Neutrófilos en cáncer pediátrico: detección y significado clínico en plasma y tejido

Datos básicos

Código:
2024-0183-1_SEHOP_BENAVENT
Protocolo:
2024-0183-1_SEHOP_BENAVENT
EUDRACT:
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Dotación:
20.000,00 €
Año de incio:
2024
Año de finalización:
2025
PI BIOMÉDICA NACIONAL Finan. Competitiva Privada

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

FUNDACION DE LA SOCIEDAD ESPAÑOLA DE HEMATOLOGIA Y ONCOLOGIAS PEDIATRICAS

Resultados del Ensayo Clínico


[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.

Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda

Article. 10.1016/j.farma.2024.12.007. 2025


Alectinib in pediatric patients with solid or CNS tumors harboring ALK-fusions: Emerging pharmacokinetic data from the iMATRIX alectinib phase I/II open-label, multi-center study

Doz, Francois; (...); Gajjar, Amar J.

Meeting Abstract. https://doi.org/10.1200/JCO.2024.42.16_suppl.3098. 2024

  • Open Access.

Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities.

Velasco Puyó P; (...); Astigarraga I

Article. 10.1002/pbc.31120. 2024


Comprehensive Screening of Genetic Variants in the Coding Region of F8 in Severe Hemophilia A Reveals a Relationship with Disease Severity in a Colombian Cohort.

Sarmiento Doncel, Samuel; (...); Lopez Guerrero, Jose A

Article. 10.3390/life14081041. 2024

  • Open Access.

Correction to: Spanish registry of hemoglobinopathies and rare anemias (REHem- AR): demographics, complications, and management of patients with ß-thalassemia.

Bardón-Cancho EJ; (...); Cela E

Correction. 10.1007/s00277-024-05838-1. 2024

  • Open Access.

Delving into the clinical impact of NETs in pediatric cancer.

Benavent N; (...); Medina P

Article. 10.1038/s41390-024-03437-4. 2024


Development and testing of a mobile app for systematic collection of patient-reported outcomes (PROs) in patients with hemophilia.

Megias-Vericat, J E; (...); Poveda Andres, J L

Letter. 10.1016/j.thromres.2024.109122. 2024


Differences in the expression of microRNAs 16-5p and 451a after acute exercise in patients with thrombosis versus healthy subjects

Lopez, Veronica Sanchez; (...); Candelera, Remedios Otero

Meeting Abstract. 10.1183/13993003.congress-2024.PA535. 2024

  • Open Access.

Dysregulated neutrophil extracellular traps and haemostatic biomarkers as diagnostic tools and therapeutic targets in periprosthetic joint infection.

Oto, Julia; (...); Medina, Pilar

Article. 10.1302/0301-620X.106B9.BJJ-2024-0187.R1. 2024


International benchmarking of childhood cancer survival by tumour stage: First results of the BENCHISTA project

Pritchard-Jones, K.; (...); Gatta, G.

Meeting Abstract. 2024


International benchmarking of stage at diagnosis for six childhood solid tumours (the BENCHISTA project): a population-based, retrospective cohort study.

Botta, Laura; (...); Pritchard-Jones, Kathy

Article. 10.1016/S2352-4642(24)00302-X. 2025


Mental, emotional and social dimensions of quality of life and their relationship with physical and functional status in adults with haemophilia.

Rodríguez MA; (...); Chimeno-Hernández A

Article. 10.1016/j.thromres.2024.109181. 2024

  • Open Access.

Metabolomic study for the identification of symptomatic carotid plaque biomarkers

Botello-Marabotto, Marina; (...); Miralles, Manuel

Article. 10.1016/j.talanta.2024.127211. 2025

  • Open Access.

Moderate haemophilia A: Recommendations from a Spanish panel of experts.

Álvarez Román MT; (...); López-Jaime FJ

Article. 10.1111/hae.15110. 2024

  • Open Access.

Prognostic significance of mutation type and chromosome fragility in Fanconi anemia.

Ramirez, Maria Jose; (...); Surralles, Jordi

Article. 10.1002/ajh.27520. 2024

  • Open Access.

Reproducibility Analysis of Radiomic Features on T2-weighted MR Images after Processing and Segmentation Alterations in Neuroblastoma Tumors.

Veiga-Canuto, Diana; (...); Marti-Bonmati, Luis

Article. 10.1148/ryai.230208. 2024

  • Open Access.

Suitability and readiness assessment of organizational resources for the implementation of gene therapy in hemophilia in Spain and Portugal: A survey-based study.

Villas JMC; (...); Álvarez-Román MT

Letter. 10.1016/j.thromres.2024.109180. 2024


Superior Live Birth Rates, Reducing Sperm DNA Fragmentation (SDF), and Lowering Miscarriage Rates by Using Testicular Sperm Versus Ejaculates in Intracytoplasmic Sperm Injection (ICSI) Cycles from Couples with High SDF: A Systematic Review and Meta-Analysis

Cano-Extremera, Marina; (...); Puchalt, Nicolas Garrido

Review. 10.3390/biology14020130. 2025


Survival and Health Care Burden of Children With Retinoblastoma in Europe.

Virgili G; (...); Gatta G

Article. 10.1001/jamaophthalmol.2024.4140. 2024

  • Open Access.

The Potential of Extracellular Microvesicle-microRNAs in Precapillary Pulmonary Hypertension.

Tura-Ceide, Olga; (...); Barbera, Joan Albert

Article. 10.1165/rcmb.2024-0282LE. 2025


Thrombotic risk and features of patients with inferior vena cava agenesis: a multicentre, retrospective, observational study.

Bravo-Perez, Carlos; (...); Corral, Javier

Article. 10.1016/S2352-3026(24)00138-8. 2024


Validation of urine p-cresol glucuronide as renal cell carcinoma non-invasive biomarker

Oto, Julia; (...); Medina, Pilar

Article. 10.1016/j.jprot.2024.105357. 2025


Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker?

Lopez-Carrasco, Amparo; (...); Noguera, Rosa

Article. 10.3390/ijms25168733. 2024

  • Open Access.

Compartir